AKVANO® expand_more
Pharma expand_more
Business scope expand_more

Company expand_more
Investors expand_more
- Investors expand_more
- Investerare expand_more
Media expand_more

AKVANO® expand_more
Pharma expand_more
Business scope expand_more

Company expand_more
Investors expand_more
- Investors expand_more
- Investerare expand_more
Media expand_more

Home / IR kontakt / Pressmeddelanden

IR kontakt
Företrädesemission 2024
Pressmeddelanden
Finansiella rapporter
Finansiell kalender
Bolagsstyrning
Aktien
- Aktieägare
- Incitamentsprogram
Börsintroduktion & prospekt
- TO1
Presentationer
Prenumerera

Investor menu

IR kontakt
Företrädesemission 2024
Pressmeddelanden
Finansiella rapporter
Finansiell kalender
Bolagsstyrning
Aktien
- Aktieägare
- Incitamentsprogram
Börsintroduktion & prospekt
- TO1
Presentationer
Prenumerera

Pressmeddelanden

sv

/investerare/pressmeddelanden/pm

The information on this website is of general information nature and is not intended to replace personal medical advice from doctors and other healthcare professionals. Lipidor’s pharma products are investigational drugs and are not approved for commercial use.

Privacy policy